NCT02634541View on ClinicalTrials.gov

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis

PHASE4UnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Ankylosing Spondyloarthritis

Interventions

DRUG

Adalimumab

Biologic drug

OTHER

PET/CT imaging

PET/CT imaging

Trial Locations (2)

Unknown

RECRUITING

Helsinki University Central Hospital, Helsinki

RECRUITING

Päijät-Häme Central Hospital, Lahti

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

University of Helsinki

OTHER